GERON CORP Amortization of Debt Issuance Costs and Discounts
GERON CORP (GERN) reported Amortization of Debt Issuance Costs and Discounts of $584.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-05
- GERON CORP amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $298.00K, a 13.74% increase year-over-year.
- GERON CORP amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $286.00K, a 13.04% increase year-over-year.
- GERON CORP amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $283.00K.
- GERON CORP amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $273.00K, a 32.09% decline year-over-year.
- GERON CORP amortization of debt issuance costs and discounts for fiscal 2025 was $1.07M.
- GERON CORP amortization of debt issuance costs and discounts for fiscal 2024 was -$3.11M, a 385.66% decline from fiscal 2023.
- GERON CORP amortization of debt issuance costs and discounts for fiscal 2023 was $1.09M, a 18.01% decline from fiscal 2022.
- GERON CORP amortization of debt issuance costs and discounts for fiscal 2022 was $1.33M, a 48.60% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $584.00K 10-Q · filed 2026-08-05 | $867.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $286.00K 10-Q · filed 2026-05-06 | $569.00K derived: sum of 2 quarters · filed 2026-05-06 | $842.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $556.00K derived: sum of 2 quarters · filed 2026-03-02 | $818.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.07M 10-K · filed 2026-03-02 |
| 2025-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $535.00K derived: sum of 2 quarters · filed 2026-08-05 | $788.00K 10-Q · filed 2025-11-07 | -$4.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $515.00K 10-Q · filed 2026-08-05 | -$4.49M derived: sum of 3 quarters · filed 2026-08-05 | -$4.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $253.00K 10-Q · filed 2026-05-06 | -$4.75M derived: sum of 2 quarters · filed 2026-05-06 | -$4.35M derived: sum of 3 quarters · filed 2026-05-06 | -$3.66M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$4.60M derived: sum of 2 quarters · filed 2026-03-02 | -$3.91M derived: sum of 3 quarters · filed 2026-03-02 | -$3.11M 10-K · filed 2026-03-02 |
| 2024-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.09M derived: sum of 2 quarters · filed 2025-11-07 | $1.89M 10-Q · filed 2025-11-07 | $2.24M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.49M 10-Q · filed 2025-08-06 | $1.84M derived: sum of 3 quarters · filed 2026-03-02 | $2.09M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $802.00K 10-Q · filed 2025-05-07 | $1.15M derived: sum of 2 quarters · filed 2026-03-02 | $1.40M derived: sum of 3 quarters · filed 2026-03-02 | $1.65M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $601.00K derived: sum of 2 quarters · filed 2026-03-02 | $846.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.09M 10-K · filed 2026-03-02 |
| 2023-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $500.00K derived: sum of 2 quarters · filed 2024-11-07 | $742.00K 10-Q · filed 2024-11-07 | $966.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $487.00K 10-Q · filed 2024-08-08 | $711.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.11M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $242.00K 10-Q · filed 2024-05-02 | $466.00K derived: sum of 2 quarters · filed 2025-02-27 | $865.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.22M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $623.00K derived: sum of 2 quarters · filed 2025-02-27 | $978.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.33M 10-K · filed 2025-02-27 |
| 2022-09-30 | $399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $754.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.10M 10-Q · filed 2023-11-02 | $1.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $704.00K 10-Q · filed 2023-08-03 | $970.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.22M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $349.00K 10-Q · filed 2023-05-11 | $615.00K derived: sum of 2 quarters · filed 2024-02-28 | $868.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $519.00K derived: sum of 2 quarters · filed 2024-02-28 | $713.00K derived: sum of 3 quarters · filed 2024-02-28 | $893.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $447.00K derived: sum of 2 quarters · filed 2022-11-07 | $627.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $374.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $180.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $179.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |